NO880731L - Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater. - Google Patents

Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.

Info

Publication number
NO880731L
NO880731L NO880731A NO880731A NO880731L NO 880731 L NO880731 L NO 880731L NO 880731 A NO880731 A NO 880731A NO 880731 A NO880731 A NO 880731A NO 880731 L NO880731 L NO 880731L
Authority
NO
Norway
Prior art keywords
pharmasoeytic
procedure
preparation
naphthalene derivatives
active naphthalene
Prior art date
Application number
NO880731A
Other languages
English (en)
Other versions
NO880731D0 (no
Inventor
David Thomas Connor
Paul Charles Unangst
Robert James Weikert
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO880731D0 publication Critical patent/NO880731D0/no
Publication of NO880731L publication Critical patent/NO880731L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Nye naftalenderivater sed formel (X). hvori X er oksygen eller svovel;. Rer alkyl aed 1 til 12 karbonatoaer;. og. R; og >«r uavhengig hydrogen, lavere alkyl, lavere alkoksy, sulfhydryl, halogen, trifluormetyl, lavere alkyltio, lavere alkylsulfinyl, lavere alkylsulfonyl, hydrokay, nitro, aaino, nono-lavere-alkyl eller di-lavere-alkylaaino. eller tatt sanmen er aetylendloksy. «ed det forbehold at 8 ikke ha blandede oksydasjonstrinn; og farmasøytisk godtagbare salter derav.Oe nye forbindelser har antiallergisk og antiinflammatorisk virkning.Fremstilling av forbindelsene er beskrevet.
NO880731A 1987-02-20 1988-02-19 Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater. NO880731L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/016,811 US4767776A (en) 1987-02-20 1987-02-20 N-1H-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents

Publications (2)

Publication Number Publication Date
NO880731D0 NO880731D0 (no) 1988-02-19
NO880731L true NO880731L (no) 1988-08-22

Family

ID=21779114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880731A NO880731L (no) 1987-02-20 1988-02-19 Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.

Country Status (16)

Country Link
US (1) US4767776A (no)
EP (1) EP0279466B1 (no)
JP (1) JPS63222161A (no)
KR (1) KR880009948A (no)
AT (1) ATE89556T1 (no)
AU (1) AU596054B2 (no)
DE (1) DE3881073T2 (no)
DK (1) DK84088A (no)
ES (1) ES2054715T3 (no)
FI (1) FI880748A (no)
IE (1) IE61482B1 (no)
NO (1) NO880731L (no)
NZ (1) NZ223477A (no)
PH (1) PH24687A (no)
PT (1) PT86785B (no)
ZA (1) ZA88385B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5257726A (en) * 1985-08-14 1993-11-02 Ing. Erich Pfeiffer Gmbh & Co. Kg Dispenser for flowable media
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5434188A (en) * 1994-03-07 1995-07-18 Warner-Lambert Company 1-ether and 1-thioether-naphthalene-2-carboxamides as inhibitors of cell adhesion and as inhibitors of the activation of HIV
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
EP1549598A4 (en) * 2002-06-07 2008-01-23 Cortical Pty Ltd naphthalene derivatives; WHICH LIMIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF THE MIGRATION INHIBITORY FACTOR (MIF) OF MACROPHAGES
JP2006526608A (ja) * 2003-06-05 2006-11-24 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド
CA2527779A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-substituted indoles and derivatives thereof as therapeutic agents
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
CA2527341A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
BRPI0411092A (pt) * 2003-06-05 2006-07-18 Warner Lambert Co benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos
BRPI0410913A (pt) * 2003-06-05 2006-06-27 Warner Lambert Co benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
US7318709B2 (en) * 2003-08-27 2008-01-15 Haldex Brake Corporation Pump valve assembly
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013092834A1 (en) * 2011-12-21 2013-06-27 Syngenta Limited Herbicidal compounds
CN104395304A (zh) * 2012-04-27 2015-03-04 巴斯夫欧洲公司 取代的n-(四唑-5-基)-和n-(三唑-5-基)芳基羧酰胺化合物及其作为除草剂的用途
WO2014184073A1 (en) * 2013-05-15 2014-11-20 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343827A (en) * 1971-06-15 1974-01-16 Science Union & Cie Acylaminotetrazoles and process for preparing them
BE789822A (fr) * 1971-10-08 1973-04-06 Allen & Hanburys Ltd Nouveaux composes heterocycliques
US4145350A (en) * 1972-09-06 1979-03-20 Burroughs Wellcome Co. Cyclic sulphur compounds triazolyl substituted phenoxathin 10, 10 dioxides
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
US4147694A (en) * 1977-02-07 1979-04-03 Riker Laboratories, Inc. 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
US4474792A (en) * 1979-06-18 1984-10-02 Riker Laboratories, Inc. N-Tetrazolyl benzamides and anti-allergic use thereof

Also Published As

Publication number Publication date
ATE89556T1 (de) 1993-06-15
IE880125L (en) 1988-08-20
DK84088A (da) 1988-08-21
IE61482B1 (en) 1994-11-02
DE3881073D1 (de) 1993-06-24
EP0279466A3 (en) 1989-08-02
EP0279466A2 (en) 1988-08-24
NZ223477A (en) 1990-01-29
FI880748A (fi) 1988-08-21
JPS63222161A (ja) 1988-09-16
ZA88385B (en) 1989-09-27
AU596054B2 (en) 1990-04-12
NO880731D0 (no) 1988-02-19
EP0279466B1 (en) 1993-05-19
FI880748A0 (fi) 1988-02-17
AU1111988A (en) 1988-09-01
PT86785B (pt) 1992-05-29
KR880009948A (ko) 1988-10-06
US4767776A (en) 1988-08-30
DE3881073T2 (de) 1993-09-02
DK84088D0 (da) 1988-02-18
PH24687A (en) 1990-09-07
ES2054715T3 (es) 1994-08-16
PT86785A (pt) 1988-03-01

Similar Documents

Publication Publication Date Title
NO880731L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
AU7886087A (en) Imide derivatives ,and their production and use
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO159854C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive beta-karbolin-3-karboksylsyrederivater.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
NO171499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
NO173389C (no) Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
AU2013888A (en) Uricosuric composition
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
NO162239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO870499D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.